Gilead Sciences, Inc. - Insider Trading & Ownership

Entity: Company
Location: 333 Lakeside Dr, Foster City, CA
Summary: The estimated value of insider holdings of Gilead Sciences, Inc. is at least $1.07B dollars as of June 20, 2024. Gilead Sciences, Inc. is the 10%+ Owner of Arcus Biosciences, Inc. and owns shares of Arcus Biosciences, Inc. (RCUS) stock worth about $631M. Gilead Sciences, Inc. is the 10%+ Owner of Arcellx, Inc. and owns shares of Arcellx, Inc. (ACLX) stock worth about $371M. Gilead Sciences, Inc. is the 10%+ Owner of ASSEMBLY BIOSCIENCES, INC. and owns shares of ASSEMBLY BIOSCIENCES, INC. (ASMB) stock worth about $19M. Gilead Sciences, Inc. is the 10%+ Owner of LEAP THERAPEUTICS, INC. and owns shares of LEAP THERAPEUTICS, INC. (LPTX) stock worth about $15.2M. Gilead Sciences, Inc. is the 10%+ Owner of HOOKIPA Pharma Inc. and owns shares of HOOKIPA Pharma Inc. (HOOK) stock worth about $13.6M. Gilead Sciences, Inc. is the 10%+ Owner of Allovir, Inc. and owns shares of Allovir, Inc. (ALVR) stock worth about $11.2M. Gilead Sciences, Inc. is the 10%+ Owner of Xilio Therapeutics, Inc. and owns shares of Xilio Therapeutics, Inc. (XLO) stock worth about $8.53M.
All Insider Reports: All Insider Reports

Ownership of Gilead Sciences, Inc.

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
RCUS	Arcus Biosciences, Inc.	10%+ Owner	$631M	+$320M	+103%	Jan 29, 2024
ACLX	Arcellx, Inc.	10%+ Owner	$371M			Dec 28, 2023
ASMB	ASSEMBLY BIOSCIENCES, INC.	10%+ Owner	$19M			Jun 17, 2024
LPTX	LEAP THERAPEUTICS, INC.	10%+ Owner	$15.2M			Apr 10, 2024
HOOK	HOOKIPA Pharma Inc.	10%+ Owner	$13.6M			Dec 20, 2023
ALVR	Allovir, Inc.	10%+ Owner	$11.2M			Jun 27, 2023
XLO	Xilio Therapeutics, Inc.	10%+ Owner	$8.53M	+$3.32M	+63.7%	Apr 2, 2024
KYTX	Kyverna Therapeutics, Inc.	10%+ Owner				Feb 12, 2024

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.